Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin

• RECKAMP KL

収録刊行物

• J Thorac Oncol

  J Thorac Oncol 3 117-124, 2008

詳細情報

• CRID: 1571980076117212544
• NII論文ID: 10027198097
• データソース種別:
  • CiNii Articles